1 / 7

Vermillion, Inc. (VRML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Companyprofilesandconferences.com glad to promote a new report on "Vermillion, Inc. (VRML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" offers innovative method to detect, monitor and manage the treatment of gynecologic cancers and other related diseases.

companyprofile
Download Presentation

Vermillion, Inc. (VRML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vermillion, Inc. (VRML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Company Profiles and Conferences

  2. Summary Vermillion, Inc. (VRML) is a molecular diagnostics company. The company offers innovative method to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. It operates under one reportable segment, Novel Diagnostic Tests. VRML’s Novel Diagnostic Tests segment develops diagnostic products for the identification of three diseases, namely, peripheral artery disease (PAD), thrombotic thrombocytopenic purpura (TTP), and ovarian cancer. The company offers products such as ovarian tumor triage test (OVA1), OVA2 and VASCLIR. It develops novel blood test (VASCLIR) for the diagnosis of peripheral artery disease (PAD) in collaboration with Stanford University. VRML’s ovarian tumor triage test is a simple blood test cleared by the FDA to help physicians assess the likelihood. The company also introduced OVAT2 for evaluating and validating biomarkers of ovarian cancer in collaboration with our colleagues at Johns Hopkins University. It has entered into collaborations with Johns Hopkins University School of Medicine (JHU); University College London (UCL); Mob +919223375060 / 919223767111

  3. the University of Texas Medical Branch (UTMB); and Copenhagen University Hospital (Rigshospitalet). VRML is headquartered in Austin, Texas, the US. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Mob +919223375060 / 919223767111

  4. Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Mob +919223375060 / 919223767111

  5. Table of Contents 1. Vermillion, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 2. Vermillion, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 3. Vermillion, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 4. Vermillion, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 5. Vermillion, Inc., Medical Devices Deals, 2008 to YTD 2014 6. Vermillion, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 7. Vermillion, Inc., Pharmaceuticals & Healthcare, Deal Details 8. Vermillion Completes Private Placement Of Shares US$18 Million Upon Exercise Of Warrants Mob +919223375060 / 919223767111

  6. Custom Research There are times when you may not find the company profile of your choice in our database. If that is the case then you must go for customized research. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us at a unique position to take up Custom Research demands of the customers.  We provide the specifications of the custom research job to a dedicated team comprising of researchers, analysts and industry experts, who have close experience and understanding of global markets, competitive landscapes, various business models, market shares, drivers, restraints and benchmarks. The Custom Research is highly insightful and actionable.  Mob +919223375060 / 919223767111

  7. To know more: Vermillion, Inc. (VRML) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Contact Us : Mob : +919223375060 / 919223767111Fax: +91 22 27810778 Email id : info@companyprofilesandconferences.com www.companyprofilesandconferences.com

More Related